TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis study findings have been reported by scientists at Jilin University
May 12th, 2009
"Tuberculosis remains the worldwide infectious disease," scientists in Changchun, People's Republic of China report. "To identify the therapeutic potential of M. vaccae in treating tuberculosis, M. vaccae was injected into Mycobacterium tuberculosis (M. tuberculosis) infected mice. The optimal dose of M. vaccae (22.5 mu g/mouse) treated mice showed lower pathological change index, spleen weight index, lung weight index and vital M. tuberculosis count than those of the untreated group. Treatment with M. vaccae enhanced the percentages of CD3(+) and CD4(+) T cells, IFN-gamma(+)CD4(+) T cells, innate immune cells including NK cells, NK1.1(+) T cells and gamma delta T...
Source: TB & Outbreaks Week (2009-05-12)
|
